Company intelligence / Profile preview

Ava Science

Zurich, Switzerlandpmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

The Ava bracelet is clinically validated to detect the fertile window in real time using multiple physiological signals. Peer-reviewed studies confirm its accuracy for ovulation prediction and cycle tracking. Over 50,000 pregnancies have been documented among users as of late 2020.

Therapeutic areas: Women's Health
Modalities: Device (wearable sensor bracelet)Digital diagnostics and therapeutics
Industry: Physiological Monitoring

Partnerships

Aristo Pharma (Germany)Carrot employer fertility benefits program (US)

Beyond the preview

Go deeper on Ava Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ava Science.

Explore the full profile